compound glp 1 news National Minority Quality Forum Launches “Health Not Hype” Campaign During Obesity Care Week to Warn Patients About Risks of Compounded GLP-1 Drugs Compound versions of GLP-1 drugs

Value of GLP-1 receptor agonists versus long-acting insulins for type 2 diabetes patients with and without established cardiovascular or chronic kidney diseases: a model-based cost-effectiveness analysis using real-world data

Active Gallbladder Disease: Patients with active gallstones or gallbladder issues, as rapid weight loss can worsen these conditions

Creating end-to-end health programs for GLP-1 users: GLP-1 therapy creates needs beyond medication, prompting demand for integrated health frameworks

122124 Patient education is critical to ensure awareness of biliary complications, emphasizing gradual weight loss, balanced diets, and regular physical activity to optimize bile composition and motility

Italy became the first country in the world to officially recognise obesity as a chronic, recurring disease through a new law, a landmark step even as reimbursement policies across Europe remain fragmented